Axsome Therapeutics AXSM Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 92.6%+1.2pp | 91.4%+1.0pp | 90.4%+0.8pp | 89.6%— | |
| Operating margin | -26.1%+46.6pp | -72.7%+12.9pp | -85.7%+274pp | -359.3%— | |
| Net margin | -28.7%+45.8pp | -74.5%+13.9pp | -88.4%+286pp | -374%— | |
| EBITDA margin | -25%+45.9pp | -70.9%+12.2pp | -83.1%+267pp | -350.5%— | |
| Free cash flow margin | -14.9%+18.5pp | -33.4%+20.5pp | -53.8%+180pp | -234.3%— | |
| Returns | |||||
| Return on equity | -252.1%-20.5pp | -231.6%-72.4pp | -159.2%+140pp | -299%-97.5pp | |
| Return on assets | -29.1%+20.5pp | -49.7%+2.4pp | -52%+37.2pp | -89.3%+5.9pp | |
| Efficiency | |||||
| Asset turnover | 1×+0.3× | 0.7×+0.1× | 0.6×+0.3× | 0.2×— | |
| Inventory turnover | 2.2×0.0× | 2.2×-0.5× | 2.7×— | —— | |
| Liquidity | |||||
| Current ratio | 1.6×-0.6× | 2.1×-1.5× | 3.6×+1.1× | 2.5×-1.2× | |
| Quick ratio | 1.5×-0.6× | 2×-1.5× | 3.5×+1.0× | 2.5×-1.3× | |
| Cash ratio | 0.9×-0.5× | 1.4×-1.4× | 2.8×+0.7× | 2.1×-1.7× | |
| Leverage | |||||
| Debt-to-equity | 2.5×-0.9× | 3.4×+2.4× | 1×+0.1× | 0.9×-2.3× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×-0.3× | |
| Per Share | |||||
| Book value per share | $1.77+49.2% | $1.19-71.7% | $4.20+56.0% | $2.69+549% | |
| Valuation | |||||
| Market capitalization | $9.21B+125% | $4.1B+8.9% | $3.77B+12.4% | $3.35B+131% | |
| Enterprise value | $9.1B+129% | $3.98B+11.5% | $3.57B+9.9% | $3.24B+130% | |
| Price / sales | 14.4×+3.8× | 10.6×-3.3× | 13.9×-53.1× | 67×— | |
| Price / book | 104.3×+32.4× | 71.9×+52.2× | 19.7×-10.9× | 30.6×-62.0× | |
| EV / sales | 14.3×+3.9× | 10.3×-2.9× | 13.2×-51.7× | 64.9×— | |
| Free cash flow yield | -1%+2.1pp | -3.1%+0.7pp | -3.9%-0.4pp | -3.5%+4.0pp | |
| Earnings yield | -2%+5.0pp | -7%-0.7pp | -6.4%-0.8pp | -5.6%+3.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Axsome Therapeutics's profit margins?
- Axsome Therapeutics (AXSM) runs a 92.6% gross margin and a -24.4% operating margin, with a -26.6% net margin.
- Where do Axsome Therapeutics's ratios come from?
- Every ratio is computed from Axsome Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
